Target intelligence / Profile preview

Fimbriae type 2 and type 3 of Bordetella pertussis (Fim2 and Fim3)

Target
Fim2 and Fim3
Molecular classification
Protein, Adhesin, Surface antigen, Type 1 pilus family
01

Overview

Fimbriae type 2 and type 3 of Bordetella pertussis are long, thin, filamentous protein structures on the bacterial surface that act as adhesins, enabling the attachment of Bordetella pertussis to ciliated respiratory epithelial cells. Encoded by the fim2 and fim3 genes, these proteins are essential for colonization, immune modulation, and biofilm formation. They serve as major antigens in acellular pertussis vaccines, as antibody responses against Fim2 and Fim3 can prevent or reduce the severity of infection. Structural differences and phase variation in fimbrial antigen expression may impact strain virulence and vaccine effectiveness.

Other names
Fimbriae type 2 (Fim2)Fimbriae type 3 (Fim3)FIM2FIM3Bordetella pertussis agglutinogen 2, agglutinogen 3
02

Mechanism of action

Vaccine-induced antibodies target fimbrial antigens, preventing bacterial adhesion and colonization by neutralizing the pathogen (immune response induction)

03

Biological functions

Adhesion to respiratory epitheliumColonizationImmune modulationBiofilm formation
04

Disease associations

InfectionWhooping cough (pertussis)
05

Safety considerations

Typical vaccine-related adverse events (injection site reactions, fever)Potential for strain variation and reduced vaccine efficacy over time
06

Interacting drugs

Acellular pertussis vaccines containing Fimbrial antigens, including: Adacel

4 more in the full profile.

07

Biomarkers

Anti-fimbrial antibodies (IgG, IgA)

Beyond the preview

Go deeper on Fimbriae type 2 and type 3 of Bordetella pertussis (Fim2 and Fim3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fimbriae type 2 and type 3 of Bordetella pertussis (Fim2 and Fim3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call